In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma. (2022)

First Author: Younger NT

Attributed to: Mutagenesis and its Biomedical Impact funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-21-2556

PubMed Identifier: 35074757

Publication URI: http://europepmc.org/abstract/MED/35074757

Type: Journal Article/Review

Volume: 82

Parent Publication: Cancer research

Issue: 8

ISSN: 0008-5472